adenocarcinoma


Also found in: Dictionary, Thesaurus, Medical, Acronyms, Wikipedia.

adenocarcinoma:

see neoplasmneoplasm
or tumor,
tissue composed of cells that grow in an abnormal way. Normal tissue is growth-limited, i.e., cell reproduction is equal to cell death. Feedback controls limit cell division after a certain number of cells have developed, allowing for tissue repair
..... Click the link for more information.
.

adenocarcinoma

[¦ad·ən‚ō‚kär·sən′ō·mə]
(medicine)
A malignant tumor originating in glandular or ductal epithelium and tending to produce acinic structures.
References in periodicals archive ?
Although AMACR has been a useful diagnostic marker for prostate adenocarcinoma in western countries, its effectiveness in Pakistani populations has not been reported.
On the malignant end it has to be differentiated from early invasive adenocarcinoma (see the Differential Diagnosis section for endocervical ADC).
studied 168 cases (stomach adenocarcinoma = 149, gastroesophageal junction adenocarcinoma = 16 and oesophageal adenocarcinoma = 3) for Her-2 staining by IHC and FISH, and used Hercep test scoring of breast cancer.
Univariate and multivariate analyses were conducted to relate IDO expression and histopathologic parameters with survival of patients with pancreatic adenocarcinoma using the Cox proportional hazards regression model.
The mean age at presentation for mucinous adenocarcinoma is about 50 years with a male preponderance of 4:1.
The hysterectomy specimen showed serous adenocarcinoma in continuity with APA, indicating coexistence of APA with serous carcinoma.
The case was diagnosed as nasal adenocarcinoma based on clinical, gross, cytological and histopathological observations.
The report provides a snapshot of the global therapeutic landscape of Lung Adenocarcinoma
The report provides a snapshot of the global therapeutic landscape of Metastatic Adenocarcinoma of The Pancreas
1,3,10) The relative rarity of ductal cancer and its frequent admixture with acinar adenocarcinoma further complicates its histological recognition.
Advanced adenocarcinoma patients with the poorest prognosis received an even more pronounced benefit from VARGATEF plus docetaxel, compared to docetaxel alone, after first-line chemotherapy: Adenocarcinoma patients whose disease progressed within nine months of starting first-line chemotherapy (T